Stemline Therapeutics Inc. (STML) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $6.20, Stemline Therapeutics Inc. dropped to $5.88 for a new 52-week low. By the closing bell, the company's stock was at $5.97 a share for a loss of 2.93%.
Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.
However one plays it, it's often a critical moment for any stock and should be noted by investors.
Stemline Therapeutics Inc. saw 355,199 shares of its stock trade hands, that's out of 18 million shares outstand. The stock has an average daily volume of 94,918 shares. After hitting a new 52-week low, Stemline Therapeutics Inc. enters the new trading day with a market cap of 107.45 million, a 50-day SMA of $7.95 and a 200-day SMA of $11.18
For a complete fundamental analysis analysis of Stemline Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for STML. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.
Stemline Therapeutics Inc. has 27 employees, is led by CEO Ivan Bergstein, and makes its home in New York, NY.
Stemline Therapeutics Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.
The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).
All data provided by QuoteMedia and was accurate as of 4:30PM ET.